- Home
- AVTX vs CIA Comparison
AVTX vs CIA Comparison
Compare AVTX & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- CIA
- Stock Information
- Founded
- AVTX 2011
- CIA 1969
- Country
- AVTX United States
- CIA United States
- Employees
- AVTX N/A
- CIA N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- AVTX Health Care
- CIA Finance
- Exchange
- AVTX Nasdaq
- CIA Nasdaq
- Market Cap
- AVTX 248.3M
- CIA 286.2M
- IPO Year
- AVTX 2015
- CIA N/A
- Fundamental
- Price
- AVTX $15.14
- CIA $5.64
- Analyst Decision
- AVTX Strong Buy
- CIA
- Analyst Count
- AVTX 9
- CIA 0
- Target Price
- AVTX $30.14
- CIA N/A
- AVG Volume (30 Days)
- AVTX 412.1K
- CIA 115.1K
- Earning Date
- AVTX 11-06-2025
- CIA 11-06-2025
- Dividend Yield
- AVTX N/A
- CIA N/A
- EPS Growth
- AVTX N/A
- CIA N/A
- EPS
- AVTX N/A
- CIA 0.21
- Revenue
- AVTX $192,000.00
- CIA $247,020,000.00
- Revenue This Year
- AVTX N/A
- CIA $4.22
- Revenue Next Year
- AVTX N/A
- CIA $4.46
- P/E Ratio
- AVTX N/A
- CIA $26.75
- Revenue Growth
- AVTX N/A
- CIA N/A
- 52 Week Low
- AVTX $3.39
- CIA $2.90
- 52 Week High
- AVTX $19.41
- CIA $6.36
- Technical
- Relative Strength Index (RSI)
- AVTX 48.12
- CIA 48.56
- Support Level
- AVTX $14.16
- CIA $5.60
- Resistance Level
- AVTX $16.03
- CIA $6.36
- Average True Range (ATR)
- AVTX 1.27
- CIA 0.38
- MACD
- AVTX -0.42
- CIA -0.02
- Stochastic Oscillator
- AVTX 23.40
- CIA 30.84
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.